Heartland Group Holdings Limited Financials

Market Capitalization A$686.3 Million as of July 1, 2024

Valuations Metrics as of May. 5, 2024

Trailing PE	8.59
Forward PE
Price to Sales TTM	A$2.91
Price to Book MRQ	A$0.66
Enterprise to Revenue	12.69
Enterprise to EBITDA

Financial Reports as of Jun. 30, 2023

Financials

Fiscal Year Ends	2023-06-30
Most Recent Quarter	2023-06-30
Profit Margin	34.10%
Operating Margin	46.49%
Return on Assets TTM	1.10%
Return on Equity TTM	8.33%

Income Statement

Revenue TTM	A$226,119,453
Revenue per Share TTM	A$0.35
Quarterly Revenue Growth	-10.10%
Gross Profit TTM	A$0
EBITDA	A$0
Net Income to Common TTM	A$77,116,639
Diluted EPS TTM	A$0.11
Quarterly Earnings Growth YoY	-22.70%

Balance Sheet

Total Cash MRQ	A$162,361,788
Total Cash per Share MRQ	A$0.25
Total Debt MRQ	A$
Total Debt to Equity MRQ	2.35
Current Ratio MRQ
Book Value per Share MRQ	A$1.43

Cash Flow

Operating Cash Flow TTM	A$-328,319,052
Levered Free Cash Flow TTM	A$95,868,000

HGH Stock Info as of May. 5, 2024

Stock Statistics

Shares Outstanding	732,552,000
Float Shares	629,830,416
Avg 10 Volume	47,235
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	14.01%
% Held by Institutions	4.00%

Stock Price Summary

Beta	0.97
Fifty Two Week Low	A$0.95
Fifty Two Week High	A$1.73
Fifty Two Week Change	-53.44%
Day 50 MA	A$1.09
Day 200 MA	A$1.38

Dividends and Splits

Forward Annual Dividend Rate	A$0.16
Forward Annual Dividend Yield	16.93%
Trailing Annual Dividend Rate	A$0.10
Trailing Annual Dividend Yield	10.58%
Payout Ratio	96.93%
Dividend Date
Ex Dividend Date	2024-03-05
Last Split Factor
Last Split Date